Literature DB >> 663252

Diagnosis of cerebral lesions by Thallium 201.

D Ancri, J Y Basset, M F Lonchampt, C Etavard.   

Abstract

The authors describe the diagnostic possibilities of Thallium 201 in cerebral lesions of various kinds. Two radiopharmaceuticals were used in 124 patients: thallium 201 citrate and technetium-99m pertechnetate labelled. When 201Tl was used, all cases of definite cerebral lesion gave a positive result within 10 minutes of injection. In 85.4% the definition was better, and small metastases which were invisible with 99mTc could be demonstrated. More than two-thirds of the time, neoplastic lesions were better defined and distinguished from adjacent normal areas of hyperactivity. 201Tl promises greater diagnostic usefulness with an examination time of only 30 minutes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 663252     DOI: 10.1148/128.2.417

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging.

Authors:  M Ricci; P Pantano; A Pierallini; D Di Stefano; A Santoro; L Bozzao; G L Lenzi
Journal:  Eur J Nucl Med       Date:  1996-05

2.  Unsuspected widespread cardiac sarcoma in a child.

Authors:  Michael E Spieth; Darcy I Kasner; Latha Prasannan
Journal:  Clin Med Res       Date:  2003-07

3.  201Tl-SPECT and 1H-MRS study of benign lateral ventricle tumors: differential diagnosis of subependymoma.

Authors:  Tomohiro Kawaguchi; Toshihiro Kumabe; Hiroaki Shimizu; Mika Watanabe; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2004-12-03       Impact factor: 3.042

4.  Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors.

Authors:  S Kosuda; H Fujii; S Aoki; K Suzuki; Y Tanaka; O Nakamura; N Shidara
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

5.  Tumour uptake of thallium-201 chloride.

Authors:  F R Hudson; D L Dewey; A R Galpine; A G Whittingham
Journal:  Eur J Nucl Med       Date:  1979-08-01

6.  Different thallium-201 single-photon emission tomographic patterns in benign and aggressive meningiomas.

Authors:  E Tedeschi; A Soricelli; A Brunetti; M Romano; A Bucciero; G Iaconetta; A Alfieri; A Postiglione; M Salvatore
Journal:  Eur J Nucl Med       Date:  1996-11

7.  Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.

Authors:  T Kuwert; C Morgenroth; B Woesler; P Matheja; S Palkovic; B Vollet; S Samnick; U Maasjosthusmann; H Lerch; F J Gildehaus; H Wassmann; O Schober
Journal:  Eur J Nucl Med       Date:  1996-10

8.  Time sequential single photon emission computed tomography studies in brain tumour using thallium-201.

Authors:  T Ueda; Y Kaji; S Wakisaka; K Watanabe; H Hoshi; S Jinnouchi; S Futami
Journal:  Eur J Nucl Med       Date:  1993-02

9.  The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment.

Authors:  Y Yoshii; M Satou; T Yamamoto; Y Yamada; A Hyodo; T Nose; H Ishikawa; R Hatakeyama
Journal:  Eur J Nucl Med       Date:  1993-01

10.  Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours.

Authors:  R A Dierckx; J J Martin; A Dobbeleir; R Crols; I Neetens; P P De Deyn
Journal:  Eur J Nucl Med       Date:  1994-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.